|
| œŽ@–¼ |
| |
X˜e@r˜a |
| |
Toshikazu Moriwaki@ |
| |
|
| œŠ@‘® |
| |
’}”g‘åŠw@iŠw“àŠ‘®:—Õ°ˆãŠwŒnj‘åŠw‰@@
lŠÔ‘‡‰ÈŠwŒ¤‹†‰È@޾г§ŒäˆãŠwêU
|
| |
|
| œE@–¼ |
| |
uŽt |
| |
|
| œŠw@ˆÊ |
| |
”ŽŽmiˆãŠwj(’}”g‘åŠw) |
| |
|
| œê–啪–ì |
| |
Á‰»Ší•aŠwA‚ª‚ñ‰»Šw—Ö@ |
| |
|
| œŒ¤‹†ƒe[ƒ} |
| |
|
| |
|
| œŠ‘®Šw‰ïEŠw‰ï–ðˆõ |
| |
E“ú–{“à‰ÈŠw‰ï
E“ú–{Á‰»Ší•aŠw‰ï
E“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï
E“ú–{—Õ°Žîᇊw‰ï
E“ú–{ŠàŽ¡—Êw‰ï
E“ú–{ˆÝŠàŠw‰ï |
| |
|
| œ’˜‘E˜_•¶ |
| |
Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y, Okayama Y, Oka T, Shirao K. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer, Vol.98(4):832-839,2008 |
| |
Nasu J, Nishina T, Hirasaki S, Moriwaki T, Hyodo I, Kurita A, Nishimura R. Predictive factors of lymph node metastasis in patients with undifferentiated early gastric cancers. J Clin Gastroenterol, Vol.40, 412-415, 2006 |
| |
Moriwaki T, Hyodo I, Nishina T, Hirao K, Tsuzuki T, Hidaka S, Kajiwara T, Endo S, Nasu J, Hirasaki S, Masumoto T, Kurita A. A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer. Cancer Chemother Pharmacol, Vol.56, 138-144, 2005 |
| |
Hirasaki S, Tanimizu M, Moriwaki T, Hyodo I, Shinji T, Koide N, Shiratori Y. Efficacy of clinical pathway for the management of mucosal gastric carcinoma treated with endoscopic submucosal dissection using an insulated-tip diathermic knife. Intern Med, Vol.43, 1120-1125, 2004 |
| |
Hyodo I, Nishina T, Moriwaki T, Endo S, Terao T, Hirao K, Nasu J, Hirasaki S, Endo H, Masumoto T, Tajiri H, Kurita A. A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting. Eur J Cancer, Vol.39, 2328-2333, 2003 |
| |
|
| œŠwpŠÖŒWŽóÜ |
| |
|
| |
|
| œtelEfax |
| |
tel : 029-853-3218 |
| |
fax : 029-853-3218 |
| |
|
| œƒ[ƒ‹ƒAƒhƒŒƒX |
| |
tmoriwak md.tsukuba.ac.jp |
|